Ultragenyx Pharmaceutical (RARE) Enterprise Value Growth (3y) (2016 - 2026)
Ultragenyx Pharmaceutical (RARE) Enterprise Value Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 2.45 Bn | 2.05 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.59% |
| Dec 31, 2025 | 3.45% |
| Sep 30, 2025 | 22.21% |
| Jun 30, 2025 | 3.98% |
| Mar 31, 2025 | 6.61% |
| Dec 31, 2024 | 6.61% |
| Sep 30, 2024 | 5.88% |
| Jun 30, 2024 | 3.34% |
| Mar 31, 2024 | 24.71% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 16.72% |
| Jun 30, 2023 | -18.04% |
| Mar 31, 2023 | 1.73% |
| Dec 31, 2022 | 0.33% |
| Sep 30, 2022 | -19.02% |
| Jun 30, 2022 | 4.25% |
| Mar 31, 2022 | 5.78% |
| Dec 31, 2021 | -17.21% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -15.62% |